Austar Lifesciences Limited (HKG:6118)
Hong Kong · Delayed Price · Currency is HKD 0.8200
0.00 (0.00%)
May 11, 2026, 4:08 PM HKT
Austar Lifesciences Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 33.81 | 16.08 | -113.47 | 87.46 | 277.3 |
Depreciation & Amortization | 43.28 | 47.46 | 39.63 | 33.81 | 29.62 |
Other Amortization | 5.9 | 5.64 | 5.92 | 3.2 | 2.35 |
Loss (Gain) From Sale of Assets | 0.47 | 0.2 | -4.1 | 0.3 | 0.72 |
Asset Writedown & Restructuring Costs | - | - | - | - | 1.09 |
Loss (Gain) From Sale of Investments | -3.67 | 3.81 | 31.89 | -3.21 | 6.24 |
Loss (Gain) on Equity Investments | -4.63 | -0.3 | -6.73 | -9.54 | -209.65 |
Other Operating Activities | 18.94 | 1.88 | 97.08 | 28.66 | 44.69 |
Change in Accounts Receivable | 3.53 | 35.7 | -39.46 | -299.98 | -259.11 |
Change in Inventory | -52.49 | 10.87 | 85.55 | 32.04 | -222.69 |
Change in Accounts Payable | 11.71 | -36.54 | -74.97 | 103.01 | 124.87 |
Change in Unearned Revenue | 60.51 | 17.44 | -200.8 | -83.33 | 145.51 |
Change in Other Net Operating Assets | 14.75 | -3.44 | 104.6 | 68.46 | -44.39 |
Operating Cash Flow | 132.1 | 98.81 | -62.65 | -37.93 | -103.45 |
Operating Cash Flow Growth | 33.70% | - | - | - | - |
Capital Expenditures | -23.1 | -20.49 | -69.24 | -117.11 | -100.57 |
Sale of Property, Plant & Equipment | 0.23 | 2.07 | 0.17 | 0.05 | 0.17 |
Cash Acquisitions | - | 2.82 | - | - | - |
Sale (Purchase) of Intangibles | -0.44 | -2.59 | -1.71 | -19.33 | -15.31 |
Investment in Securities | 1 | 9 | 4.51 | -21.86 | 164.26 |
Other Investing Activities | 9.36 | 13.63 | 11.8 | 5.1 | 16.47 |
Investing Cash Flow | -12.95 | 4.43 | -54.47 | -153.14 | 65.02 |
Long-Term Debt Issued | 389.73 | 303.14 | 442.36 | 246.88 | 109.1 |
Total Debt Issued | 389.73 | 303.14 | 442.36 | 246.88 | 109.1 |
Long-Term Debt Repaid | -433.62 | -387.56 | -271.76 | -116.39 | -45.35 |
Total Debt Repaid | -433.62 | -387.56 | -271.76 | -116.39 | -45.35 |
Net Debt Issued (Repaid) | -43.89 | -84.43 | 170.6 | 130.49 | 63.75 |
Other Financing Activities | -14.02 | -16.9 | -23.49 | -5.19 | -4.4 |
Financing Cash Flow | -57.91 | -101.32 | 147.12 | 125.3 | 59.35 |
Foreign Exchange Rate Adjustments | -0.66 | 1.13 | 0.14 | 0.95 | -0.42 |
Net Cash Flow | 60.59 | 3.04 | 30.14 | -64.82 | 20.5 |
Free Cash Flow | 109 | 78.31 | -131.88 | -155.04 | -204.02 |
Free Cash Flow Growth | 39.18% | - | - | - | - |
Free Cash Flow Margin | 7.12% | 5.22% | -7.48% | -7.19% | -10.13% |
Free Cash Flow Per Share | 0.21 | 0.15 | -0.26 | -0.30 | -0.40 |
Cash Interest Paid | 11.98 | 17.15 | 13.86 | 9.36 | 4.4 |
Cash Income Tax Paid | 7.6 | 6.88 | 7.4 | 15.69 | 7.81 |
Levered Free Cash Flow | 117.55 | 55.82 | -88.74 | -182.04 | -237.32 |
Unlevered Free Cash Flow | 125.02 | 66.45 | -80.01 | -176.04 | -234.56 |
Change in Working Capital | 38.01 | 24.03 | -125.07 | -179.81 | -255.8 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.